Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Functionally selective alpha2C adrenoreceptor agonists

Functionally selective alpha2C adrenoreceptor agonists

US Patent 8383818 · Granted Feb 26, 2013

Estimated economic value: $57,688,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as 2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Hormone receptor modulators for treating metabolic conditions and disorders2025
C26-linked rapamycin analogs as mTOR inhibitors2025
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors2023
Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof2023
Hormone receptor modulators for treating metabolic mutagenic and fibrotic condit2023
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as 2023
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators2023
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors2023
C26-linked rapamycin analogs as mTOR inhibitors2023
Polycyclic compounds as allosteric SHP2 inhibitors2023